Women want BRAC screening, study shows:
This article was originally published in Clinica
Executive Summary
A US survey of 74 women with a family history of breast cancer found that 80% of them wanted to be screened for possession of the BRAC 1 and BRAC 2 breast cancer susceptibility genes. Most patients in the Moffat Cancer Center study in Florida said that knowing their susceptibility would motivate them to practice self-examination and go for mammography more frequently (Psychosomatic Medicine, Sept/Oct).
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.